Epsilon M&A Deal Report - Unither Pharmaceuticals
Transaction Multiples for the Valuation of Private Companies
Private Group led by Ardian / Unither Pharmaceuticals
No EMAT :
82231
Announced Date :
18/11/2016
Type :
SBO (Secondary Buy Out) ,Exit
Deal Value :
Yes
Acquirer :
Private Group led by Ardian
Target :
Unither Pharmaceuticals
Country :
France
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Laboratory Testing Services
Business Description :
Unither Pharmaceuticals is a Contract Development and Manufacturing Organization (CDMO) . > Offers a comprehensive range of products: sterile unit-doses, non-sterile liquids, liquid sticks...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
ns | |||||
| Current |
|
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 128
- Number of EMAT Reports / sub-sector « Laboratory Testing Services » = 36
| Date | Acquirer | Target | Country | Multiples | See details |
| 28/10/2016 | Private Group led by JB Capital Markets | Vitaldent | Spain | ** | 82092 |
| 09/11/2016 | Mittel | Gruppo Zaffiro | Italy | * | 81784 |
Source: Epsilon Research / EMAT
